Abstract
Caffeine is an excellent model compound for understanding drugs of abuse/dependence (HOLTZMAN 1990). Historically, caffeine use dates back hundreds, possibly thousands, of years (GRAHAM 1984). Caffeine use spread worldwide from its initially constrained geographical origins, despite recurring efforts to restrict or eliminate its use motivated on moral, economic, political, religious or medical grounds (AUSTIN 1979). Currently, caffeine use is almost universal, with more than 80% of adults in North America regularly consuming behaviorally active doses of caffeine (GILBERT 1976; GRAHAM 1978; HUGHES et al. 1993b). The broad generality of caffeine self-administration is reflected in the facts that, worldwide, caffeine consumption occurs in markedly different vehicles (e.g., drinking of coffee, tea, maté, soft drinks; chewing of kola nuts; consumption of cocoa and guarana products) and in widely different, but culturally well-integrated, social contexts (e.g., the coffee break in the United States; tea time in the United Kingdom; kola nut chewing in Nigeria). The dependence-producing nature of caffeine is reflected in the experience of most people who know someone who has expressed a “need” for a cup of coffee or who claimed to be “addicted” to coffee or their morning caffeinated beverage of choice. Consistent with this anecdotal experience, a recent random–digit telephone survey found that about 17% of current caffeine users met the DSM-III-Rpsychiatric criteria for being moderately or severely drug dependent on caffeine (HUGHES et al. 1993b).
Keywords
- Discriminative Stimulus
- Subjective Effect
- Psychomotor Stimulant
- Caffeine Withdrawal
- Discriminative Stimulus Property
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, access via your institution.
Buying options
Preview
Unable to display preview. Download preview PDF.
References
Ahlijanian MK, Takemori AE (1986) Cross-tolerance studies between caffeine and (–)-N6-(Phenylisopropyl)-adenosine (PIA) in mice. Life Sci 38:577–588
Ammon HPT, Bieck PR, Mandalaz D, Verspohl EJ (1983) Adaptation of blood pressure to continuous heavy coffee drinking in young volunteers. A double-blind crossover study. Br J Clin Pharmacol 15:701–706
Ando K, Yanagita T (1992) Effects of an antitussive mixture and its consituents in rats discriminating methamphetamine from saline. Pharmacol Biochem Behav 41:783–788
Atkinson J, Ensslen M (1976) Self-administration of caffeine by the rat. Arzneimittelforschung 26:2059–2061
Austin GA (1979) Perspectives on the history of psychoactive substance use. In: NIDA research issues 24, DHEW publication no (ADM) 79-810. US Government Printing Office, Washington DC, pp 50 – 66
Beecher HK (1959) Measurement of subjective responses: quantitative effects of drugs. Oxford University Press, New York
Biaggioni I, Paul S, Puckett A, Arzubiaga C (1991) Caffeine and theophylline as adenosine receptor antagonists in humans. J Pharmacol Exp Ther 258:588–593
Bonnet MH, Arand DL (1992) Caffeine use as a model of acute and chronic insomnia. Sleep 15:526–536
Boyd EM, Dolman M, Knight LM, Sheppard EP (1965) The chronic oral toxicity of caffeine. Can J Physiol Pharmacol 43:995–1007
Bozarth MA (1987) Methods of assessing the reinforcing properties of abused drugs. Springer, Berlin Heidelberg New York
Carney JM (1982) Effects of caffeine, theophylline and theobromine on scheduled controlled responding in rats. Br J Pharmacol 75:451–454
Carney JM, Christensen HD (1980) Discriminative stimulus properties of caffeine: studies using pure and natural products. Pharmacol Biochem Behav 13:313
Carney JM, Holloway FA, Modrow HE (1985) Discriminative stimulus properties of methylxanthines and their metabolites in rats. Life Sci 36:913–920
Carroll ME, Hagen EW, Asencio M, Brauer LH (1989) Behavioral dependence on caffeine and phencyclidine in rhesus monkeys: interactive effects. Pharmacol Biochem Behav 31:927–932
Chait LD, Griffiths RR (1983) Effects of caffeine on cigarette smoking behavior and subjective response. Clin Pharmacol Ther 34:612–622
Chait LD, Johanson CE (1988) Discriminative stimulus effects of caffeine and benzphetamine in amphetamine-trained volunteers. Psychopharmacology (Berl) 96:302–308
Charney DS, Galloway MP, Heninger GR (1984) The effects of caffeine on plasma MHPG, subjective anxiety, autonomic symptoms and blood pressure in healthy humans. Life Sci 35:135–144
Choi OH, Shamim MT, Padgett WL, Daly JW (1988) Caffeine and theophylline analogues: correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors. Life Sci 43:387–398
Chou DT, Khan S, Forde J, Hirsh KR (1985) Caffeine tolerance: behavioral, electrophysiological and neurochemical evidence. Life Sci 36:2347–2358
Coffin VL, Carney JM (1983) Behavioral pharmacology of adenosine analogs. In: Daly JW, Kuroda Y, Phillis JW, Shimizu H, Ui M (eds) Physiology and pharmacology of adenosine derivatives. Raven, New York, pp 267–274
Collins RJ, Weeks JR, Cooper MM, Good PI, Russell RR (1984) Prediction of abuse liability of drugs using IV self-administration by rats. Psychopharmacology (Berl) 82:6–13
Daly JW (1993) Mechanism of action of caffeine. In: Garattini S (ed) Caffeine, coffee and health. Raven, New York, pp 97–150
Denaro CP, Brown CR, Jacob P III, Benowitz NL (1991) Effects of caffeine with repeated dosing. Eur J Clin Pharmacol 40:273–278
Deneau G, Yanagita T, Seevers MH (1969) Self-administration of psychoactive substances by the monkey: a measure of psychological dependence. Psychopharmacologia 16:30–48
Dworkin SI, Vrana SL, Broadbent J, Robinson JH (1993) Comparing the effects of nicotine, caffeine, methylphenidate and cocaine. Med Chem Res 2:593–602
Evans SM, Griffiths RR (1991a) Dose-related caffeine discrimination in normal volunteers: individual differences in subjective effects and self-reported cues. Behav Pharmacol 2:345–356
Evans SM, Griffiths RR (1991b) Low-dose caffeine physical dependence in normal subjects: dose-related effects. In: Harris LS (ed) Problems of drug dependence 1990. US Government Printing Office, Washington DC, p 446
Evans SM, Griffiths RR (1992) Caffeine tolerance and choice in humans. Psychopharmacology (Berl) 108:51–59
Evans SM, Critchfield TS, Griffiths RR (1994) Caffeine reinforcement demonstrated in a majority of moderate caffeine users. Behav Pharmacol 5:231–238
Fennelly M, Galletly DC, Puride GI (1991) Is caffeine withdrawal the mechanism of postoperative headache? Anesth Analg 72:449–453
Finn IB, Holtzman SG (1986) Tolerance to caffeine-induced stimulation of locomotor activity in rats. J Pharmacol Exp Ther 238:542–546
Finn IB, Holtzman SG (1987) Pharmacologic specificity of tolerance to caffeine-induced stimulation of locomotor activity. Psychopharmacology (Berl) 93:428–434
Finn IB, Holtzman SG (1988) Tolerance and cross-tolerance to theophylline-induced stimulation of locomotor activity in rats. Life Sci 42:2475–2482
Foltin RW, Fischman MW (1991) Assessment of abuse liability of stimulant drugs in humans: a methodological survey. Drug Alcohol Depend 28:3–48
Galletly DC, Fennelly M, Whitwam JG (1989) Does caffeine withdrawal contribute to postanaesthetic morbidity? Lancet 10:1335
Gauvin DV, Harland RD, Michaelis RC, Holloway FA (1989) Caffeinephenylethylamine combinations mimic the cocaine discriminative cue. Life Sci 44:67–73
Gauvin DV, Criado JR, Moore KR, Holloway FA (1990) Potentiation of cocaine’s discriminative effects by caffeine: a time-effect analysis. Pharmacol Biochem Behav 36:195–197
Gauvin DV, Moore KR, Youngblood BD, Holloway FA (1993) The discriminative stimulus properties of legal, over-the-counter stimulants administered singly and in binary and ternary combinations. Psychopharmacology (Berl) 110:309–319
Gilbert RM (1976) Caffeine as a drug of abuse. In: Gibbins RJ, Israel Y, Kalant H, Popham RE, Schmidt W, Smart RG (eds) Research advances in alcohol and drug problems, vol 3. Wiley, New York, pp 49–176
Goldberg SR, Henningfield JE (1988) Reinforcing effects of nicotine in humans and experimental animals responding under intermittent schedules of IV drug injection. Pharmacol Biochem Behav 30:227–234
Goldstein A, Kaizer S (1969) Psychoactive effects of caffeine in man. III. A questionnaire survey of coffee drinking and its effects in a group of housewives. Clin Pharmacol Ther 10:477–488
Goudie AJ, Atkinson J, West CR (1986) Discriminative properties of the psychostimulant dl-cathinone in a two lever operant task: lack of evidence for dopaminergic mediation. Neuropharmacology 25:85–94
Graham DM (1978) Caffeine – its identity, dietary sources, intake and biological effects. Nutr Rev 36:97–102
Graham HN (1984) Tea: the plant and its manufacture; chemistry and consumption of the beverage. In: Spiller GA (ed) The methylxanthine beverages and foods: chemistry, consumption and health effects. Liss, New York, pp 29–74
Green RM, Stiles GL (1986) Chronic caffeine ingestion sensitizes the A1 adenosine receptor-adenylate cyclase system in rat cerebral cortex. J Clin Invest 77:222–227 Griffiths RR, Woodson PP (1988a) Caffeine physical dependence: a review of human and laboratory animal studies. Psychopharmacology (Bert) 94:437–451
Griffiths RR, Woodson PP (1988b) Reinforcing effects of caffeine in humans. J Pharmacol Exp Ther 246:21–29
Griffiths RR, Woodson PP (1988c) Reinforcing properties of caffeine: studies in humans and laboratory animals. Pharmacol Biochem Behav 29:419–427
Griffiths RR, Brady JV, Bradford LD (1979) Predicting the abuse liability of drugs with animal drug self-administration procedures: psychomotor stimulants and hallucinogens. In: Thompson T, Dews PB (eds) Advances in behavioral pharmacology, vol 2. Academic, New York, pp 163–208
Griffiths RR, Bigelow GE, Liebson IA (1986a) Human coffee drinking: reinforcing and physical dependence producing effects of caffeine. J Pharmacol Exp Ther 239:416–425
Griffiths RR, Bigelow GE, Liebson IA, O’Keeffe M, O’Leary D, Russ N (1986b) Human coffee drinking: manipulation of concentration and caffeine dose. J Exp Anal Behav 45:133–148
Griffiths RR, Bigelow GE, Liebson IA (1989) Reinforcing effects of caffeine in coffee and capsules. J Exp Anal Behav 52:127–140
Griffiths RR, Evans SM, Heishman SJ, Preston KL, Sannerud CA, Wolf B, Woodson PP (1990a) Low-dose caffeine discrimination in humans. J Pharmacol Exp Ther 252:970–978
Griffiths RR, Evans SM, Heishman SJ, Preston KL, Sannerud CA, Wolf B, Woodson PP (1990b) Low-dose caffeine physical dependence in humans. J Pharmacol Exp Ther 255:1123–1132
Griffiths RR, Mumford GK (1995) Caffeine: a drug of abuse? In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven, New York, pp 1699–1713
Harland RD, Gauvin DV, Michaelis RC, Carney JM, Seale TW, Holloway FA (1989) Behavioral interaction between cocaine and caffeine: a drug discrimination analysis in rats. Pharmacol Biochem Behav 32:1017–1023
Hirsh K (1984) Central nervous system pharmacology of the dietary methylxanthines. In: Spiller GA (ed) The methylxanthine beverages and foods: chemistry, consumption, and health effects. Liss, New York, pp 235–301
Holloway FA, Michaelis RC, Huerta PL (1985a) Caffeine-phenylethylamine combinations mimic the amphetamine discriminative cue. Life Sci 36:723–730
Holloway FA, Modrow HE, Michaelis RC (1985b) Methylxanthine discrimination in the rat: possible benzodiazepine and adenosine mechanisms. Pharmacol Biochem Behav 22:815–824
Holloway FA, Goulden KL, Gauvin DV (1992) Masking of the chlordiazepoxide (CDP) cue by caffeine (CAF) in a three-choice CDP-SAL-CAF drug discrimination task. Soc Neurosci Abstr 18:813
Holtzman SG (1983) Complete, reversible, drug-specific tolerance to stimulation of locomotor activity by caffeine. Life Sci 33:779–787
Holtzman SG (1986) Discriminative stimulus properties of caffeine in the rat: noradrenergic mediation. J Pharmacol Exp Ther 239:706–714
Holtzman SG (1987) Discriminative stimulus effects of caffeine: tolerance and crosstolerance with methylphenidate. Life Sci 40:381–389
Holtzman SG (1990) Caffeine as a model drug of abuse. Trends Pharmacol Sci 11:355–356
Holtzman SG (1991) CGS 15943, a nonxanthine adenosine receptor antagonist: effects on locomotor activity of nontolerant and caffeine-tolerant rats. Life Sci 49:1563–1570
Holtzman SG, Finn IB (1988) Tolerance to behavioral effects of caffeine in rats. Pharmacol Biochem Behav 29:411–418
Holtzman SG, Mante S, Minneman KP (1991) Role of adenosine receptors in caffeine tolerance. J Pharmacol Exp Ther 256:62–68
Howell LL (1993) Comparative effects of caffeine and selective phosphodiesterase inhibitors on respiration and behavior in rhesus monkeys. J Pharmacol Exp Ther 266:894–903
Hughes JR (1992) Clinical importance of caffeine withdrawal. N Engl J Med 327 (16):1160–1161
Hughes JR (1993) Smoking is a drug dependence: a reply to Robinson and Pritchard. Psychopharmacology (Berl) 113:282–283
Hughes JR, Higgins ST, Bickel WK, Hunt WK, Fenwick JW, Gulliver SB, Mireault GC (1991) Caffeine self-administration, withdrawal, and adverse effects among coffee drinkers. Arch Gen Psychiatry 48:611–617
Hughes JR, Hunt WK, Higgins ST, Bickel WK, Fenwick JW, Pepper SL (1992a) Effect of dose on the ability of caffeine to serve as a reinforcer in humans. Behav Pharmacol 3:211–218
Hughes JR, Oliveto AH, Bickel WK, Higgins ST, Valliere W (1992b) Caffeine selfadministration and withdrawal in soda drinkers, J Addict Dis 4:178
Hughes JR, Oliveto AH, Bickel WK, Higgins ST, Badger GJ (1993a) Caffeine selfadministration and withdrawal: incidence, individual differences and interrelationships. Drug Alcohol Depend 32:239–246
Hughes JR, Oliveto AH, Helzer JE, Bickel WK, Higgins ST (1993b) Indications of caffeine dependence in a population-based sample. In: Harris LS (ed) Problems of drug dependence, 1992. US Government Printing Office, Washington DC, p 194
Jaffe JH, Jaffe FK (1989) Historical perspectives on the use of subjective effects measures in assessing the abuse potential of drugs. In: Fischman MW, Mello NK (eds) Testing for abuse liability of drugs. NIDA monograph no 92, DHHS publication no (ADM) 89-1613. US Government Printing Office, Washington DC, pp 43–72
Jones CN, Howard JL, McBennett ST (1980) Stimulus properties of antidepressants in the rat. Psychopharmacology (Berl) 67:111–118
Kalant H, LeBlanc AE, Gibbins RJ (1971) Tolerance to, and dependence on, some non-opiate psychotropic drugs. Pharmacol Rev 23:135–191
Kamien JB, Bickel WK, Hughes JR, Higgins ST, Smith B (1993) Drug discrimination by humans compared to nonhumans: current status and future directions. Psychopharmacology (Berl) 111:259–270
Kaplan GB, Greenblatt DJ, Kent MA, Cotreau-Bibbo MM (1993) Caffeine treatment and withdrawal in mice: relationships between dosage, concentrations, locomotor activity and A1 adenosine receptor binding. J Pharmacol Exp Ther 266:1563–1572
Katz JL, Goldberg SR (1987) Psychomotor stimulant effects of caffeine alone and in combination with an adenosine analog in the squirrel monkey. J Pharmacol Exp Ther 242:179–187
Kuhn DM, Appel JB, Greenberg I (1974) An analysis of some discriminative properties ofd-amphetamine. Psychopharmacologia 39:57–66
Leathwood PD, Pollet P (1983) Diet-induced mood changes in normal populations. J Psychiatr Res 17:147–154
Lieberman HR, Wurtman RJ, Emde GG, Coviella ILG (1987) The effects of caffeine and aspirin on mood and performance. J Clin Psychopharmacol 7:315–320
Llosa T (1993) Special issue on oral cocaine in humans. Clín Adicc Quím (J Chem Addict) 4:1–26
Loke WH (1988) Effects of caffeine on mood and memory. Physiol Behav 44:367–372
Mariathasan EA, Stolerman IP (1992) Drug discrimination studies in rats with caffeine and phenylpropanolamine administered separately and as mixtures. Psychopharmacology (Berl) 109:99–106
Mathew RJ, Wilson WH (1985) Caffeine consumption, withdrawal and cerebral blood flow. Headache 25:305–309
Mattila J, Seppala T, Mattila MJ (1988) Anxiogenic effect of yohimbine in healthy subjects: comparison with caffeine and antagonism by clonidine and diazepam. Int Clin Psychopharmacol 3: 215–229
Modrow HE, Holloway FA (1985) Drug discrimination and cross generalization between two methylxanthines. Pharmacol Biochem Behav 23:425–429
Modrow HE, Holloway FA, Carney JM (1981a) Caffeine discrimination in the rat. Pharmacol Biochem Behav 14:683–688
Modrow HE, Holloway FA, Christensen HD, Carney JM (1981b) Relationship between caffeine discrimination and caffeine plasma levels. Pharmacol Biochem Behav 15:323–325
Mumford GK, Holtzman SG (1991) Qualitative differences in the discriminative stimulus effects of low and high doses of caffeine in the rat. J Pharmacol Exp Ther 258:857–865
Mumford GK, Neill DB, Holtzman SG (1988) Caffeine elevates reinforcement threshold for electrical brain stimulation: tolerance and withdrawal changes. Brain Res 459:163–167
Mumford GK, Evans SM, Kaminski BJ, Preston KL, Sannerud CA, Silverman K, Griffiths RR (1994) Discrminative stimulus and subjective effects of theobromine and caffeine in humans. Psychopharmacology (Berl) 115:1–8
Nehlig A, Daval J-L, Debry G (1992) Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Brain Res Rev 17:139–170
Nikodijevic O, Jacobson KA, Daly JW (1993) Locomotor activity in mice during chronic treatment with caffeine and withdrawal. Pharmacol Biochem Behav 44:199–216
Oliveto AH, Hughes JR, Pepper SL, Bickel WK, Higgins ST (1991) Low doses of caffeine can serve as reinforcers in humans. In: Harris LS (ed) Problems of druig dependence, 1990. US Government Printing Office, Washington DC, p 442
Oliveto AH, Bickel WK, Hughes JR, Shea PJ, Higgins ST, Fenwick JW (1992a) Caffeine drug discrimination in humans: acquisition, specificity and correlation with self-reports. J Pharmacol Exp Ther 261:885–894
Oliveto AH, Hughes JR, Higgins ST, Bickel WK, Pepper SL, Shea PJ, Fenwich JW (1992b) Forced-choice versus free-choice procedures: caffeine self-administration in humans. Psychopharmacology (Berl) 109:85–91
Oliveto AH, Bickel WK, Hughes JR, Terry SY, Higgins ST, Badger GJ (1993) Pharmacological specificity of the caffeine discriminative stimulus in humans: effects of theophylline, methylphenidate and buspirone. Behav Pharmacol 4:237–246
Overton DA [ 1982 ) Comparison of the degree of discriminability of various drugs using the T-maze drug discrimination paradigm. Psychopharmacology (Berl) 76:385–395
Overton DA, Batta SK (1977) Relationship between abuse liability of drugs and their degree of discriminability in the rat. In: Thompson T, Unna KR (eds) Predicting dependence liablility of stimulant and depressant drugs. University Park Press, Baltimore, pp 125–135
Preston KL, Bigelow GE (1991) Subjective and discriminative effects of drugs. Behav Pharmacol 2:293–313
Rapoport JL, Jensvold M, Elkins R, Buchsbaum MS, Weingartner H, Ludlow C, Zahn TP, Berg CJ, Neims AH (1981) Behavioral and cognitive effects of caffeine in boys and adult males. J Nerv Ment Dis 169:726–732
Rizzo AA, Stamps LE, Fehr LA (1988) Effects of caffeine withdrawal on motor performance and heart rate changes. Int J Psychophysiol 6:9–14
Robertson D, Wade D, Workman R, Woosley RL, Oates JA (1981) Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest 67:1111–1117
Robinson JH, Pritchard WS (1992a) The meaning of addiction: reply to West. Psychopharmacology (Berl) 108:411–416
Robinson JH, Pritchard WS (1992b) The role of nicotine in tobacco use. Psychopharmacology (Berl) 108:397–407
Rosen JB, Young AM, Beuthin FC, Louis-Ferdinand RT (1986) Discriminative stimulus properties of amphetamine and other stimulants in lead-exposed and normal rats. Pharmacol Biochem Behav 24:211–215
Schechter MD (1977) Caffeine potentiation of amphetamine: implications for hyperkinesis therapy. Pharmacol Biochem Behav 6:359–361
Schechter MD (1989) Potentiation of cathinone by caffeine and nikethamide. Pharmacol Biochem Behav 33:299–301
Schuster CR, Woods JH, Seevers MH (1969) Self-administration of central stimulants by the monkey. In: Sjoqvist F, Tottie M (eds) Abuse of central stimulants. Raven, New York, pp 339–347
Shi D, Nikodijevic O, Jacobson KA, Daly JW (1993a) Chronic caffeine alters the density of adenosine, adrenergic, cholinergic, GABA, and serotonin receptors and calcium channels in mouse brain. Cell Mol Neurobiol 13:247–261
Shi J, Benowitz NL, Denaro CP, Sheiner LB (1993b) Pharmacokineticpharmacodynamic modeling of caffeine: tolerance to pressor effects. Clin Pharmacol Ther 53:6–14
Silverman PB, Schultz KA (1989) Comparison of cocaine and procaine discriminative stimuli. Drug Dev Res 16:427–433
Silverman K, Evans SM, Strain EC, Griffiths RR 1992 Withdrawal syndrome after the double–blind cessation of caffeine consumption. N Engl J Med 327:1109–1114
Silverman K, Griffiths RR (1992) Low-dose caffeine discrimination and self-reported mood effects in normal volunteers. J Exp Anal Behav 57:91–107
Silverman K, Mumford GK, Griffiths RR (1994) Enhancing caffeine reinforcement by behavioral requirements following drug ingestion. Psychopharmacology (Berl )114:424–432
Sinton CM, Petitjean F (1989) The influence of chronic caffeine administration on sleep parameters in the cat. Pharmacol Biochem Behav 32: 459 – 462
Snyder SH (1985) Adenosine as a neuromodulator. Annu Rev Neurosci 8:103–124
Snyder SH, Katims JJ, Annau Z, Bruns RF, Daly JW (1981) Adenosine receptors and behavioral actions of methylxanthines. Proc Natl Acad Sci USA 78:3260–3264
Spealman RD, Coffin VL (1988) Discriminative-stimulus effects of adenosine analogs: mediation by adenosine A2 receptors. J Pharmacol Exp Ther 246: 610 – 618
Spencer DG Jr, Lal H (1983) Discriminative stimulus properties of 1-phenylisopropyl adenosine: blockade by caffeine and generalization to 2-chloroadenosine. Life Sci 32:2329–2333
Stern KN, Chait LD, Johanson CE (1989) Reinforcing and subjective effects of caffeine in normal human volunteers. Psychopharmacology (Berl) 98:81–88
van Dusseldorp M, Katan MB (1990) Headache caused by caffeine withdrawal among moderate coffee drinkers switched from ordinary to decaffeinated coffee: a 12 week double blind trial. Br Med J 300:1558–1559
Vitiello MV, Woods SC (1977) Evidence for withdrawal from caffeine by rats. Pharmacol Biochem Behav 6: 553 – 555
von Borstel RW, Wurtman RJ, Conlay LA (1983) Chronic caffeine consumption potentiates the hypotensive action of circulating adenosine. Life Sci 32:1151–1158
Wayner MJ, Jolicoeur FB, Rondeau DB, Barone FC (1976) Effects of acute and chronic administration of caffeine on schedule dependent and schedule induced behavior. Pharmacol Biochem Behav 5: 343 – 348
Weber JG, Ereth MH, Danielson DR (1993) Perioperative ingestion of caffeine and postoperative headache. Mayo Clin Proc 68: 842 – 845
West R (1992) Nicotine addiction: a re-analysis of the arguments. Psychopharmacology (Berl) 108:408–410
Winter JC (1981) Caffeine -induced stimulus control. Pharmacol Biochem Behav 15:157–159
Yamamoto T, Miyamoto K, Ueki S (1987) Rolipram as a discriminative stimuli: transfer to phosphodiesterase inhibitors. Jpn J Pharmacol 43:165–171
Yasuhara M, Levy G (1988) Rapid development of functional tolerance to caffeine-induced seizures in rats. Proc Soc Exp Biol Med 188:185–190
Zwyghuizen-Doorenbos A, Roehrs TA, Lipschutz L, Timms V, Roth T (1990) Effects of caffeine on alertness. Psychopharmacology (Berl) 100:36–39
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Griffiths, R.R., Mumford, G.K. (1996). Caffeine Reinforcement, Discrimination, Tolerance and Physical Dependence in Laboratory Animals and Humans. In: Schuster, C.R., Kuhar, M.J. (eds) Pharmacological Aspects of Drug Dependence. Handbook of Experimental Pharmacology, vol 118. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60963-3_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-60963-3_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64631-7
Online ISBN: 978-3-642-60963-3
eBook Packages: Springer Book Archive